Medical Device Regulation Reform Promote UK Innovation and Growth

With patient safety at the forefront of the governing strategy, the UK’s Medical Device Regulation Reform presents a unique chance to promote innovation and growth in the UK life science industry.

Leaders of the main businesses and groups have revealed a new strategy to hasten the development of the UK Health Technology monitoring framework and have established an advisory committee for the Life Sciences Council to promote the achievement of the Life Sciences Vision’s goals.

The advisory committee has decided that coordinated suggestions will be released in three key areas: system capacity, international acknowledgement, and innovation channels.

The recommendations will outline how potential policies, like the adoption of electronic labelling, might lighten the load on business and free up resources in regulation processes. This may be used to create and implement cutting-edge procedures that take advantage of the opportunities presented by Brexit.

The panel will also look at how the legal structure may help the NHS Net Zero objectives be met and sustained.

This aims to encourage frequent updates during growth and implementation and increase interactions with a wide variety of stakeholders.

Furthermore, the ABHI will endeavour to compile feedback from the whole industry with the help of other trade associations, and will offer additional industry knowledge in order to show solidarity with the upcoming regulatory measures.

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.